841258-76-2 Usage
Chemical Structure
A complex structure consisting of a piperazine ring, a substituted benzoyl group, and an indazole moiety attached to it.
Ethenyl Group
Contains an ethenyl group connected to the indazole ring.
Pharmaceutical Research
Typically used in pharmaceutical research as a potential drug candidate.
Structural Features
Diverse structural features contribute to its potential as a drug candidate.
Potential Biological Activities
May have a range of potential applications in medicine.
Antipsychotic Agent
Could be used as a potential antipsychotic agent.
Antitumor Agent
May also have potential as an antitumor agent.
Further Research
More research is necessary to fully understand its properties and potential uses.
Molecular Weight
The molecular weight of the compound is approximately 362.4 g/mol.
Appearance
It is likely to be a solid at room temperature, but the exact appearance may vary.
Solubility
The solubility of the compound is not specified, but it may be soluble in organic solvents like DMSO or ethanol.
Stability
The stability of the compound is not specified, but it should be stored in a cool, dry place and protected from light to maintain its integrity.
Synonyms
The compound may have various synonyms or trade names depending on the manufacturer or supplier.
Hazards
The specific hazards of the compound are not provided, but it should be handled with care and proper safety measures due to its complex structure and potential biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 841258-76-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,1,2,5 and 8 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 841258-76:
(8*8)+(7*4)+(6*1)+(5*2)+(4*5)+(3*8)+(2*7)+(1*6)=172
172 % 10 = 2
So 841258-76-2 is a valid CAS Registry Number.
841258-76-2Relevant articles and documents
INDAZOLE DERIVATIVES
-
Page/Page column 34, (2008/06/13)
The present invention provides a compound represented by Formula (I): [whetein R1 represents CONR1aR1b (wherein R1a and R1b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R1a and R1b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, R2 represents a hydrogen atom, CONR2aR2b (wherein R2a and R2b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R2a and R2b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group), NR2cR2d (wherein R2c and R2d may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkanoyl, substituted or unsubstituted aroyl, substituted or unsubstituted heteroaroyl, substituted or unsubstituted ararkyl, substituted or unsubstituted lower alkylsulfonyl or substituted or unsubstituted lower arylsulfonyl) or the like].